Israel - Englisch - Ministry of Health

teva israel ltd - diltiazem hydrochloride - tablets - diltiazem hydrochloride 30 mg - diltiazem - diltiazem - calcium channel blocker for the treatment of angina pectoris.

Israel - Englisch - Ministry of Health

teva pharmaceutical industries ltd, israel - diltiazem hydrochloride - tablets - diltiazem hydrochloride 60 mg - diltiazem - diltiazem - calcium channel blocker for the treatment of angina pectoris.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - diltiazem hydrochloride, quantity: 360 mg - capsule, modified release - excipient ingredients: purified talc; sodium lauryl sulfate; methacrylic acid copolymer; povidone; simethicone; diethyl phthalate; tributyl acetylcitrate; maize starch; sucrose; titanium dioxide; brilliant blue fcf; potable water; gelatin; silicon dioxide - diltiazem sandoz cd is indicated for the treatment of hypertension. diltiazem sandoz cd is also indicated for the management of chronic stable angina (effort-associated angina) where there is no evidence of vasospastic or unstable angina. since the safety and efficacy of cd capsules in the management of unstable or vasospastic angina has not been substantiated, use of this formulation for these indications is not recommended.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - diltiazem hydrochloride, quantity: 240 mg - capsule, modified release - excipient ingredients: ethylcellulose; simethicone; purified talc; castor oil; tributyl acetylcitrate; white beeswax; methacrylic acid copolymer; titanium dioxide; gelatin; colloidal anhydrous silica; brilliant blue fcf; stearic acid; fumaric acid; maize starch; sucrose - diltiazem sandoz cd is indicated for the treatment of hypertension. diltiazem sandoz cd is also indicated for the management of chronic stable angina (effort-associated angina) where there is no evidence of vasospastic or unstable angina. since the safety and efficacy of cd capsules in the management of unstable or vasospastic angina has not been substantiated, use of this formulation for these indications is not recommended.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - diltiazem hydrochloride, quantity: 180 mg - capsule, modified release - excipient ingredients: fumaric acid; gelatin; methacrylic acid copolymer; brilliant blue fcf; white beeswax; stearic acid; colloidal anhydrous silica; simethicone; ethylcellulose; titanium dioxide; tributyl acetylcitrate; castor oil; purified talc; maize starch; sucrose - diltiazem sandoz cd is indicated for the treatment of hypertension. diltiazem sandoz cd is also indicated for the management of chronic stable angina (effort-associated angina) where there is no evidence of vasospastic or unstable angina. since the safety and efficacy of cd capsules in the management of unstable or vasospastic angina has not been substantiated, use of this formulation for these indications is not recommended.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

clinect nz pty limited - diltiazem hydrochloride 120.12mg - modified release capsule - 120 mg - active: diltiazem hydrochloride 120.12mg excipient: capsugel light blue turquoise blue 0588 methacrylic acid copolymer methylcellulose microcrystalline cellulose polysorbate 80 purified talc tributyl citrate - diltiazem cd is indicated for the treatment of hypertension either alone or in combination with other antihypertensive medications such as diuretics.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

clinect nz pty limited - diltiazem hydrochloride 180.1mg - modified release capsule - 180 mg - active: diltiazem hydrochloride 180.1mg excipient: capsugel light blue turquoise blue 0588 methacrylic acid copolymer methylcellulose microcrystalline cellulose polysorbate 80 purified talc tributyl citrate - diltiazem cd is indicated for the treatment of hypertension either alone or in combination with other antihypertensive medications such as diuretics.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

clinect nz pty limited - diltiazem hydrochloride 240.1mg - modified release capsule - 240 mg - active: diltiazem hydrochloride 240.1mg excipient: capsugel light blue turquoise blue 0588 methacrylic acid copolymer methylcellulose microcrystalline cellulose polysorbate 80 purified talc tributyl citrate - diltiazem cd is indicated for the treatment of hypertension either alone or in combination with other antihypertensive medications such as diuretics.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

clinect nz pty limited - diltiazem hydrochloride 300mg - modified release capsule - 300 mg - active: diltiazem hydrochloride 300mg excipient: capsugel light blue opaque 0570 capsugel light grey opaque 0945 methacrylic acid copolymer methylcellulose microcrystalline cellulose polysorbate 80 purified talc tributyl citrate - diltiazem cd is indicated for the treatment of hypertension either alone or in combination with other antihypertensive medications such as diuretics.

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - diltiazem hydrochloride (unii: olh94387te) (diltiazem - unii:ee92bbp03h) - diltiazem hydrochloride 5 mg in 1 ml - diltiazem hydrochloride injection is indicated for the following: temporary control of rapid ventricular rate in atrial fibrillation or atrial flutter. it should not be used in patients with atrial fibrillation or atrial flutter associated with an accessory bypass tract such as in wolff-parkinson-white (wpw) syndrome or short pr syndrome. rapid conversion of paroxysmal supraventricular tachycardias (psvt) to sinus rhythm. this includes av nodal reentrant tachycardias and reciprocating tachycardias associated with an extranodal accessory pathway such as the wpw syndrome or short pr syndrome. unless otherwise contraindicated, appropriate vagal maneuvers should be attempted prior to administration of diltiazem hydrochloride injection. the use of diltiazem hydrochloride injection should be undertaken with caution when the patient is compromised hemodynamically or is taking other drugs that decrease any or all of the following: peripheral resistance, myocardial filling, myocardial contractility, or electrical impu